Article Details

TolerogenixX Publishes Three-Year Follow-Up Data from Phase - GlobeNewswire

Retrieved on: 2022-09-26 08:15:03

Tags for this article:

Click the tags to see associated articles and topics

TolerogenixX Publishes Three-Year Follow-Up Data from Phase - GlobeNewswire. View article details on hiswai:

Excerpt

... from Phase I Trial of Immune Tolerance-Inducing MIC-Lx Cell Therapy ... of the immune system in transplant recipients and autoimmune patients.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up